Neurocrine Biosciences, Inc. (NBIX)
163.82
-0.06
(-0.04%)
USD |
NASDAQ |
Jun 08, 15:40
Neurocrine Biosciences Market Cap : 16.48B for June 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 28.49B |
| Amgen, Inc. | 186.40B |
| Iovance Biotherapeutics, Inc. | 1.755B |
| Voyager Therapeutics, Inc. | 202.94M |
| Incyte Corp. | 20.21B |
Market Cap Related Metrics
| PE Ratio | 25.19 |
| PS Ratio | 5.420 |
| PEG Ratio | 0.2089 |
| Price to Book Value | 4.837 |
| Price to Free Cash Flow | 20.23 |
| Price | 163.82 |
| Earnings Yield | 3.97% |
| PEGY Ratio | 0.2089 |
| Operating PE Ratio | 21.05 |
| Normalized PE Ratio | 25.55 |